(Q43980367)

28 November 2017

title

Pediatric immunohematopoietic stem cell transplantation at a tertiary care center in Cape Town (English)

1 reference

28 November 2017

0 references

Herman Waldmann

5

0 references

Geoff Hale

6

object named as

Geoffrey Hale

1 reference

28 November 2017

Lucille Wood

1

1 reference

28 November 2017

June Juritz

2

1 reference

28 November 2017

Jonathan Havemann

3

1 reference

28 November 2017

Jo Lund

4

1 reference

28 November 2017

Peter Jacobs

7

1 reference

28 November 2017

publication date

1 April 2008

1 reference

Hematology/oncology and stem cell therapy

28 November 2017

published in

1 reference

28 November 2017

volume

1

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

80-89

1 reference

Bone-marrow transplantation (first of two parts).

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Bone-marrow transplantation (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Treatment of aplastic anaemia with antilymphocyte globulin and high-dose methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Collection and cryopreservation of human stem and progenitor cells for bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

The National Marrow Donor Program. Meeting the needs of the medically underserved

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Multiplex amplification and fluorimetric detection of short tandem repeats for mixed chimerism after bone marrow transplant.

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Bone marrow transplantation for sickle cell anemia: progress and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Immune deficiency and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Fanconi's anemia, transplantation, and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Fanconi anemia: current management

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Increased intensity of acute graft-versus-host disease after reduced-intensity bone marrow transplantation compared to conventional transplantation from an HLA-matched sibling in children

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions.

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

1 reference

7 January 2021

Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath "in the bag" as T-cell depletion: the Leiden experience

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Monoclonal antibodies and cytomegalovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Improved outcomes in intermediate- and high-risk aggressive non-Hodgkin lymphoma after autologous hematopoietic stem cell transplantation substituting intravenous for oral busulfan in a busulfan, cyclophosphamide, and etoposide preparative regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Stem cell transplantation for autoimmune disorders. Immune reconstitution

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

T-lymphocyte reconstitution following rigorously T-cell-depleted versus unmodified autologous stem cell transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Elimination of instrument-driven reflex manual differential leukocyte counts. Optimization of manual blood smear review criteria in a high-volume automated hematology laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

DEB test for Fanconi anemia detection in patients with atypical phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

A risk-to-benefit analysis for central venous catheters

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

A Practical Method for Ensuring Long-Term venous access1

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Large volume leukapheresis for peripheral blood stem cell collection in children under 10 kg in weight

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulation

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Total parenteral nutrition vs oral diet in autologous hematopoietic cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

The effect of peptide stimulation on haematopoietic stem cell mobilisation including engraftment characteristics and a note on donor side effects.

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Late appearance of acute graft-vs-host disease after suspending or tapering immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Pediatric Clostridium difficile: a phantom menace or clinical reality?

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

An evidence and consensus based guideline for acute diarrhoea management

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Pain management and weaning from narcotics and sedatives

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Prevention of mucositis in bone marrow transplantation: a double blind randomised controlled trial of sucralfate

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Coordinated interdisciplinary management of pediatric intestinal failure: a 2-year review

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Enteral and parenteral nutrition: evidence-based approach.

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Is physical fitness decreased in survivors of childhood leukemia? A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

Just another cost increasing exercise (JACIE)?

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2808%2950038-0

7 January 2021

10.1016/S1658-3876(08)50038-0

Identifiers

DOI

1 reference

28 November 2017

1 reference